| Dr Roberto Manllo-karim, MD | |
|
1901 S 1st St, Ste 600, Mcallen, TX 78503-1228 | |
| (956) 631-6136 | |
| (956) 631-1848 |
| Full Name | Dr Roberto Manllo-karim |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 38 Years |
| Location | 1901 S 1st St, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891794616 | NPI | - | NPPES |
| 39005176 | Other | PALMETTO MEDICARE RAILROAD | |
| 131918803 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | J2181 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fresenius Medical Care Mcallen | Mcallen, TX | Dialysis facility |
| South Texas Dialysis Center | Mission, TX | Dialysis facility |
| Mission Kidney Center | Mission, TX | Dialysis facility |
| Mission Valley Dialysis | Mission, TX | Dialysis facility |
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| South Texas Health System | Edinburg, TX | Hospital |
| Rio Grande Regional Hospital | Mcallen, TX | Hospital |
| Mission Regional Medical Center | Mission, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Texas Nephrology Pllc | 8820403512 | 6 |
| South Texas Kidney Specialists, P.a. | 9234118837 | 15 |
News Archive
The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio-, the online open-access journal of the American Society for Microbiology.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company's Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT).
The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.
New guidelines to reduce early elective deliveries at Winnie Palmer Hospital for Women & Babies have cut by 50 percent the admission of late pre-term newborns (37-38 weeks gestation) into the neonatal intensive care unit, resulting in healthcare cost savings.
Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in — all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill."
› Verified 2 days ago
| Entity Name | South Texas Kidney Specialists, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629195177 PECOS PAC ID: 9234118837 Enrollment ID: O20040720000260 |
News Archive
The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio-, the online open-access journal of the American Society for Microbiology.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company's Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT).
The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.
New guidelines to reduce early elective deliveries at Winnie Palmer Hospital for Women & Babies have cut by 50 percent the admission of late pre-term newborns (37-38 weeks gestation) into the neonatal intensive care unit, resulting in healthcare cost savings.
Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in — all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill."
› Verified 2 days ago
| Entity Name | Southern Texas Nephrology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366039901 PECOS PAC ID: 8820403512 Enrollment ID: O20210210000874 |
News Archive
The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio-, the online open-access journal of the American Society for Microbiology.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company's Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT).
The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.
New guidelines to reduce early elective deliveries at Winnie Palmer Hospital for Women & Babies have cut by 50 percent the admission of late pre-term newborns (37-38 weeks gestation) into the neonatal intensive care unit, resulting in healthcare cost savings.
Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in — all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto Manllo-karim, MD 1901 S 1st St, Mcallen, TX 78503-1228 Ph: (956) 631-6136 | Dr Roberto Manllo-karim, MD 1901 S 1st St, Ste 600, Mcallen, TX 78503-1228 Ph: (956) 631-6136 |
News Archive
The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio-, the online open-access journal of the American Society for Microbiology.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company's Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT).
The Cystinosis Research Foundation of Irvine, Calif., announced it awarded $1.75 million in 11 new grants to researchers in the United States, Canada, Belgium and Italy who are working to find a cure for cystinosis, a rare, deadly metabolic and genetic disease that afflicts about 500 children and young adults in the U.S. and 2,000 worldwide.
New guidelines to reduce early elective deliveries at Winnie Palmer Hospital for Women & Babies have cut by 50 percent the admission of late pre-term newborns (37-38 weeks gestation) into the neonatal intensive care unit, resulting in healthcare cost savings.
Politico reports that liberals are accruing a long list of reasons to be upset about the health reform negotiations: "A single-payer plan, a public option, a state 'opt-out' of the public option, a trigger and a Medicare buy-in — all ideas pushed by Democrats and blessed by [President] Obama at various times but now gone from the bill."
› Verified 2 days ago
Dona E Cooper-dockery, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave, Ste 12, Mcallen, TX 78504 Phone: 956-686-8802 Fax: 956-686-3083 | |
Jasmine Gowarty, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1901 S Col Rowe Blvd, Mcallen, TX 78503 Phone: 956-687-5150 | |
Dr. Juan Jose Salazar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 801 E Nolana Ave Ste 2, Mcallen, TX 78504 Phone: 956-687-1177 Fax: 956-687-3290 | |
Dr. Encarnacion Rodriguez, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4300 N Mccoll Rd, Mcallen, TX 78504 Phone: 956-630-1170 | |
Rodrigo Erana, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 101 Us Expressway 83, Mcallen, TX 78503 Phone: 956-661-9840 Fax: 956-661-9841 | |
Dr. Victoria A Rodriguez-quick, MD Nephrology Medicare: Medicare Enrolled Practice Location: 501 N Ware Rd, Mcallen, TX 78501 Phone: 956-668-0044 | |
Dr. Numan A Arafat, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 500 E Ridge Rd, Suite 202, Mcallen, TX 78503 Phone: 956-686-5410 |